RITUXIMAB AND SARGRAMOSTIM IMMUNOTHERAPY FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANT FOR AGGRESSIVE NON-HODGKIN'S LYMPHOMA

被引：0
|
作者：
Scigliano, E. [1 ]
Grosskreutz, C. L. [1 ]
Osman, K. [1 ]
Malone, A. [1 ]
Nieto, J. [1 ]
Isola, L. M. [1 ]
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.167
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
136
引用
收藏
页码：S208 / S209
页数：3
相关论文
共 50 条
  • [11] Rituximab for aggressive non-Hodgkin's lymphomas relapsing or refractory to autologous stem cell transplantation
    Pan, D
    Moskowitz, CH
    Zelenetz, AD
    Straus, D
    Kewalaramani, T
    Noy, A
    Qin, J
    Teruya-Feldstein, J
    Portlock, CS
    CANCER JOURNAL, 2002, 8 (05): : 371 - 376
  • [12] Rituximab lymphoma transplant antibody therapy for non-Hodgkin's lymphoma following allogeneic stem cell transplantation.
    Seropian, S
    McGuirk, JP
    Cooper, DL
    BLOOD, 1999, 94 (10) : 387B - 387B
  • [13] Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma
    不详
    EUROPEAN JOURNAL OF CANCER CARE, 2003, 12 (04) : 306 - 307
  • [14] The role of rituximab in autologous and allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma
    Naparstek E.
    Current Hematologic Malignancy Reports, 2006, 1 (4) : 220 - 229
  • [15] Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma
    Flinn, IW
    O'Donnell, PV
    Goodrich, A
    Vogelsang, G
    Abrams, R
    Noga, S
    Marcellus, D
    Borowitz, M
    Jones, R
    Ambinder, RF
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (06) : 628 - 632
  • [16] Autologous Stem Cell Transplant in Hodgkin's and Non-Hodgkin's Lymphoma, Multiple Myeloma, and AL Amyloidosis
    Alnasser, Sulaiman Mohammed
    Alharbi, Khalid Saad
    Almutairy, Ali F.
    Almutairi, Sulaiman Mohammed
    Alolayan, Abdulmalik Mohammed
    CELLS, 2023, 12 (24)
  • [17] High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era
    Ban-Hoefen, Makiko
    Kelly, Jennifer L.
    Bernstein, Steven H.
    Liesveld, Jane
    Constine, Louis
    Becker, Michael
    Milner, Laurie
    Phillips, Gordon
    Friedberg, Jonathan W.
    LEUKEMIA & LYMPHOMA, 2012, 53 (05) : 830 - 835
  • [18] Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin's lymphoma
    Tsirigotis, Panagiotis
    Dray, Liliane
    Resnick, Igor B.
    Ackerstein, Aliza
    Gesundheit, Benjamin
    Elad, Sharon
    Or, Reuven
    Shapira, Michael-Yechiel
    ANNALS OF HEMATOLOGY, 2010, 89 (03) : 263 - 272
  • [19] Post-autologous stem cell transplantation administration of rituximab improves the outcome of patients with aggressive B cell non-Hodgkin’s lymphoma
    Panagiotis Tsirigotis
    Liliane Dray
    Igor B. Resnick
    Aliza Ackerstein
    Benjamin Gesundheit
    Sharon Elad
    Reuven Or
    Michael-Yechiel Shapira
    Annals of Hematology, 2010, 89 : 263 - 272
  • [20] Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma
    Lemieux, B
    Tartas, S
    Traulle, C
    Espinouse, D
    Thieblemont, C
    Bouafia, F
    Alhusein, Q
    Antal, D
    Salles, G
    Coiffier, B
    BONE MARROW TRANSPLANTATION, 2004, 33 (09) : 921 - 923
12345